Core Viewpoint - Fujifilm announced on November 25 that it is a major manufacturer of alpha-lipoic acid series products, alongside Tonghe Pharmaceutical, and expects a 5.47% year-on-year increase in the shipment volume of its core product, granular alpha-lipoic acid, in the first half of 2025 due to proactive market expansion strategies and flexible pricing policies [1]. Company Summary - Fujifilm is actively expanding its market presence and implementing flexible pricing strategies to enhance its product competitiveness [1]. - The company anticipates a growth in shipment volume of granular alpha-lipoic acid, indicating a positive outlook for its core product line [1]. Industry Summary - The alpha-lipoic acid market is characterized by significant competition, with Fujifilm and Tonghe Pharmaceutical being key players in the export segment [1]. - The expected growth in shipment volume reflects a broader trend of increasing demand for alpha-lipoic acid products in the market [1].
富士莱：2025年上半年，核心产品颗粒硫辛酸出货量同比增长5.47%